冠状动脉药物项目。关于右旋甲状腺素对其方案进行进一步修改的研究结果。冠状动脉药物项目研究小组。 - Suppr

Suppr

超能文献

The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group.

出版信息

JAMA. 1972 May 15;220(7):996-1008.

PMID:4337170

Abstract

摘要

相似文献

The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group.冠状动脉药物项目。关于右旋甲状腺素对其方案进行进一步修改的研究结果。冠状动脉药物项目研究小组。

JAMA. 1972 May 15;220(7):996-1008.

The Coronary Drug Project. Initial findings leading to modifications of its research protocol.

JAMA. 1970 Nov 16;214(7):1303-13.

[Serum lipid-lowering drugs following myocardial infarction].[心肌梗死后的血清降脂药物]

Dtsch Med Wochenschr. 1975 Aug 1;100(31):1611-2.

The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group.冠状动脉药物项目。导致停用每日2.5毫克雌激素组的研究结果。冠状动脉药物项目研究组。

JAMA. 1973 Nov 5;226(6):652-7.

The coronary drug project--findings with regard to estrogen, dextrothyroxine, clofibrate and niacin.冠状动脉药物项目——关于雌激素、右旋甲状腺素、氯贝丁酯和烟酸的研究结果。

Adv Exp Med Biol. 1977;82:52-75. doi: 10.1007/978-1-4613-4220-5_6.

Dextrothyroxine for lowering cholesterol.

Med Lett Drugs Ther. 1976 Jun 18;18(13):53.

Clofibrate and niacin in coronary heart disease.氯贝丁酯与烟酸治疗冠心病

JAMA. 1975 Jan 27;231(4):360-81.

The coronary drug project. Design, methods, and baseline results.

Circulation. 1973 Mar;47(3 Suppl):I1-50. doi: 10.1161/01.cir.47.3s1.i-1.

Editorial: Lipid-lowering drugs after myocardial infarction.社论：心肌梗死后的降脂药物

Lancet. 1975 Mar 1;1(7905):501-2.

[Hyperlipidemia and coronary disease].

Coeur Med Interne. 1976 Jan-Mar;15(1):3-10.

引用本文的文献

Hypovitaminosis D and Low T3 Syndrome: A Link for Therapeutic Challenges in Patients with Acute Myocardial Infarction.维生素D缺乏症与低T3综合征：急性心肌梗死患者治疗挑战的一个关联

J Clin Med. 2021 Nov 12;10(22):5267. doi: 10.3390/jcm10225267.

The Alcohol-High-Density Lipoprotein Athero-Protective Axis.酒精-高密度脂蛋白胆固醇致动脉粥样保护轴

Biomolecules. 2020 Jul 1;10(7):987. doi: 10.3390/biom10070987.

Novel uses of thyroid hormones in cardiovascular conditions.甲状腺激素在心血管疾病中的新用途。

Endocrine. 2019 Oct;66(1):115-123. doi: 10.1007/s12020-019-02050-4. Epub 2019 Oct 15.

Nonalcoholic Fatty Liver Disease and Hypercholesterolemia: Roles of Thyroid Hormones, Metabolites, and Agonists.非酒精性脂肪性肝病与高胆固醇血症：甲状腺激素、代谢物和激动剂的作用。

Thyroid. 2019 Sep;29(9):1173-1191. doi: 10.1089/thy.2018.0664.

Cholesterol: Can't Live With It, Can't Live Without It.胆固醇：有之害之，无之亦害。

Methodist Debakey Cardiovasc J. 2019 Jan-Mar;15(1):9-15. doi: 10.14797/mdcj-15-1-9.

Role of the Thyroid System in the Dynamic Complex Network of Cardioprotection.甲状腺系统在心脏保护动态复杂网络中的作用。

Eur Cardiol. 2016 Aug;11(1):36-42. doi: 10.15420/ecr.2016:9:2.

Conditional power as an aid in making interim decisions in observational studies.条件功效在观察性研究中辅助进行中期决策。

Eur J Epidemiol. 2018 Sep;33(9):777-784. doi: 10.1007/s10654-018-0413-9. Epub 2018 May 28.

Improved adherence adjustment in the Coronary Drug Project.冠状动脉药物项目中依从性调整的改善

Trials. 2018 Mar 5;19(1):158. doi: 10.1186/s13063-018-2519-5.

Direct effects of thyroid hormones on hepatic lipid metabolism.甲状腺激素对肝脏脂质代谢的直接影响。

Nat Rev Endocrinol. 2018 May;14(5):259-269. doi: 10.1038/nrendo.2018.10. Epub 2018 Feb 23.

Potential Role of Thyroid Receptor β Agonists in the Treatment of Hyperlipidemia.甲状腺受体 β 激动剂在高脂血症治疗中的潜在作用。

Drugs. 2017 Oct;77(15):1613-1621. doi: 10.1007/s40265-017-0791-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验